The ECU Health Medical Center is expanding heart care with two new technologies for transcatheter tricuspid valve replacement. The new technologies are EVOQUE™, a ...

Two state-of-the-art new technologies for transcatheter tricuspid valve replacements is expanding advanced heart care with ...

Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

Many networks across the UK and abroad will gradually switch of 3G networks in order to focus on faster, more reliable 4G and 5G networks. Customers who will be impacted by the change this month ...

This prospective cohort‐study included adult patients undergoing aortic valve surgery or ascending aortic surgery ... Additional medical and surgical information, follow‐up echocardiography data, ...

Blocking Piezo2, a protein receptor that senses mechanical forces in tissues — ones such as stress, strain, and stiffness — may be a new way to slow the progression of idiopathic pulmonary fibrosis ...

Switch 2’s new LCD screen is 7.9 inches while the Steam Deck LCD’s is 7 inches and the Steam Deck OLED’s is 7.4 inches. Valve has the upper hand when it comes to screen technology with the ...

The biotech has been evaluating 50-mg and 100-mg daily doses of its cardiac sarcomere modulator, dubbed EDG-7500, in a four-week, open-label phase 2 Cirrus-HCM trial of patients with obstructive ...

The pre-planned interim analysis for 2-week safety results from the ongoing Phase 2a biomarker study demonstrated GRI-0621 (4.5mg orally once daily) to be safe and well-tolerated in the first 12 ...